Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Bioengineering of bacterial pathogens for noninvasive imaging and in vivo evaluation of therapeutics.

Rajamani S, Kuszpit K, Scarff JM, Lundh L, Khan M, Brown J, Stafford R, Cazares LH, Panchal RG, Bocan T.

Sci Rep. 2018 Aug 22;8(1):12618. doi: 10.1038/s41598-018-30806-x.

2.

Evaluation of Volume of Intramuscular Injection into the Caudal Thigh Muscles of Female and Male BALB/c Mice (Mus musculus).

Gehling AM, Kuszpit K, Bailey EJ, Allen-Worthington KH, Fetterer DP, Rico PJ, Bocan TM, Hofer CC.

J Am Assoc Lab Anim Sci. 2018 Jan 1;57(1):35-43.

3.

The Discovery of a Novel Phosphodiesterase (PDE) 4B-Preferring Radioligand for Positron Emission Tomography (PET) Imaging.

Zhang L, Chen L, Beck EM, Chappie TA, Coelho RV, Doran SD, Fan KH, Helal CJ, Humphrey JM, Hughes Z, Kuszpit K, Lachapelle EA, Lazzaro JT, Lee C, Mather RJ, Patel NC, Skaddan MB, Sciabola S, Verhoest PR, Young JM, Zasadny K, Villalobos A.

J Med Chem. 2017 Oct 26;60(20):8538-8551. doi: 10.1021/acs.jmedchem.7b01050. Epub 2017 Oct 9.

PMID:
28957634
4.

[18F]DPA-714 PET Imaging Reveals Global Neuroinflammation in Zika Virus-Infected Mice.

Kuszpit K, Hollidge BS, Zeng X, Stafford RG, Daye S, Zhang X, Basuli F, Golden JW, Swenson RE, Smith DR, Bocan TM.

Mol Imaging Biol. 2018 Apr;20(2):275-283. doi: 10.1007/s11307-017-1118-2.

5.

Neuropathogenesis of Zika Virus in a Highly Susceptible Immunocompetent Mouse Model after Antibody Blockade of Type I Interferon.

Smith DR, Hollidge B, Daye S, Zeng X, Blancett C, Kuszpit K, Bocan T, Koehler JW, Coyne S, Minogue T, Kenny T, Chi X, Yim S, Miller L, Schmaljohn C, Bavari S, Golden JW.

PLoS Negl Trop Dis. 2017 Jan 9;11(1):e0005296. doi: 10.1371/journal.pntd.0005296. eCollection 2017 Jan.

6.

The synthesis and in vivo evaluation of [18F]PF-9811: a novel PET ligand for imaging brain fatty acid amide hydrolase (FAAH).

Skaddan MB, Zhang L, Johnson DS, Zhu A, Zasadny KR, Coelho RV, Kuszpit K, Currier G, Fan KH, Beck EM, Chen L, Drozda SE, Balan G, Niphakis M, Cravatt BF, Ahn K, Bocan T, Villalobos A.

Nucl Med Biol. 2012 Oct;39(7):1058-67. doi: 10.1016/j.nucmedbio.2012.03.011. Epub 2012 May 8.

7.

[(18)F]FLT-PET imaging does not always "light up" proliferating tumor cells.

Zhang CC, Yan Z, Li W, Kuszpit K, Painter CL, Zhang Q, Lappin PB, Nichols T, Lira ME, Affolter T, Fahey NR, Cullinane C, Spilker M, Zasadny K, O'Brien P, Buckman D, Wong A, Christensen JG.

Clin Cancer Res. 2012 Mar 1;18(5):1303-12. doi: 10.1158/1078-0432.CCR-11-1433. Epub 2011 Dec 14.

8.

PF-03732010: a fully human monoclonal antibody against P-cadherin with antitumor and antimetastatic activity.

Zhang CC, Yan Z, Zhang Q, Kuszpit K, Zasadny K, Qiu M, Painter CL, Wong A, Kraynov E, Arango ME, Mehta PP, Popoff I, Casperson GF, Los G, Bender S, Anderes K, Christensen JG, VanArsdale T.

Clin Cancer Res. 2010 Nov 1;16(21):5177-88. doi: 10.1158/1078-0432.CCR-10-1343. Epub 2010 Sep 9.

9.

Evaluation of treatment-associated inflammatory response on diffusion-weighted magnetic resonance imaging and 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography imaging biomarkers.

Galbán CJ, Bhojani MS, Lee KC, Meyer CR, Van Dort ME, Kuszpit KK, Koeppe RA, Ranga R, Moffat BA, Johnson TD, Chenevert TL, Rehemtulla A, Ross BD.

Clin Cancer Res. 2010 Mar 1;16(5):1542-52. doi: 10.1158/1078-0432.CCR-08-1812. Epub 2010 Feb 16.

10.

PF-00477736 mediates checkpoint kinase 1 signaling pathway and potentiates docetaxel-induced efficacy in xenografts.

Zhang C, Yan Z, Painter CL, Zhang Q, Chen E, Arango ME, Kuszpit K, Zasadny K, Hallin M, Hallin J, Wong A, Buckman D, Sun G, Qiu M, Anderes K, Christensen JG.

Clin Cancer Res. 2009 Jul 15;15(14):4630-40. doi: 10.1158/1078-0432.CCR-08-3272. Epub 2009 Jul 7.

11.

Proton and sodium MRI assessment of emerging tumor chemotherapeutic resistance.

Schepkin VD, Lee KC, Kuszpit K, Muthuswami M, Johnson TD, Chenevert TL, Rehemtulla A, Ross BD.

NMR Biomed. 2006 Dec;19(8):1035-42.

12.

A methodology for registration of a histological slide and in vivo MRI volume based on optimizing mutual information.

Meyer CR, Moffat BA, Kuszpit KK, Bland PL, Mckeever PE, Johnson TD, Chenevert TL, Rehemtulla A, Ross BD.

Mol Imaging. 2006 Jan-Mar;5(1):16-23.

13.

Sodium and proton diffusion MRI as biomarkers for early therapeutic response in subcutaneous tumors.

Schepkin VD, Chenevert TL, Kuszpit K, Lee KC, Meyer CR, Johnson TD, Rehemtulla A, Ross BD.

Magn Reson Imaging. 2006 Apr;24(3):273-8. Epub 2006 Jan 26.

14.

In vivo measures of dopaminergic radioligands in the rat brain: equilibrium infusion studies.

Kilbourn MR, Sherman PS, Kuszpit K.

Synapse. 2002 Mar 1;43(3):188-94.

Supplemental Content

Loading ...
Support Center